ADMA Biologics logo

ADMA Biologics

ADMA | NASDAQ
Chart Builder DCF Calculator
$13.47
-$0.21 (-1.54%)
At close: Nov 16, 2026, 4:00 PM ET
$13.74
+$0.27 (+2.03%)
After-hours: Nov 16, 2026, 7:55 PM ET
-1.54%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
80.2
-1.0 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #20/1021 (Top 2%)

Key Statistics

Market Data

Market Cap $2.99B
1D Range
13.46 14.05
52W Range
7.60 20.38

Valuation (TTM)

PE 17.49
PB 6.81
EV/EBITDA 12.14

Valuation (NTM)

Forward PE 16.68
Forward PEG 0.44
Price Target $19.50
Loading financial charts...

Profile

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These spec...

Sector Healthcare
Industry Biotechnology
Employees 644
IPO Date Oct 17, 2013
Fiscal Year January - December

Latest News

Here's Why Adma Biologics (ADMA) is a Strong Momentum Stock

3 days ago · zacks.com

Here's Why Adma Biologics (ADMA) is a Strong Momentum Stock
Why Adma Biologics (ADMA) is a Top Growth Stock for the Long-Term

5 days ago · zacks.com

Why Adma Biologics (ADMA) is a Top Growth Stock for the Long-Term
ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?

5 days ago · zacks.com

ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?
Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average

11 days ago · zacks.com

Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average

11 days ago · zacks.com

Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average
ADMA Biologics, Inc. (ADMA) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

ADMA Biologics, Inc. (ADMA) Q3 2026 Earnings Call Transcript
Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates

12 days ago · zacks.com

Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates
ADMA Biologics Q3 Earnings Call Highlights

12 days ago · marketbeat.com

ADMA Biologics Q3 Earnings Call Highlights
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note

17 days ago · zacks.com

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

19 days ago · zacks.com

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.23
Beat +16.93%
REV
$141.1M
Beat +2.17%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$19.50
Upside
+44.77%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.